Monte Rosa Therapeutics, Inc. (GLUE) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Monte Rosa Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -33.72x | -7.06x | -2.15x | -3.31x | -12.85x | -25.98x |
| P/B Ratio | 5.59x | 2.30x | 1.62x | 1.32x | 2.73x | -19.13x |
| P/S Ratio | 10.53x | 6.78x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 93.2% | 89.3% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | -43.8% | -107.3% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | -31.2% | -96.1% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | -37.1% | -96.5% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 6.12x | 2.40x | 5.07x | 10.79x | 20.96x | 1.49x |
| Quick Ratio | 6.12x | 2.40x | 5.07x | 10.79x | 20.96x | 1.49x |
| Leverage | ||||||
| Debt/Equity | 0.17x | 0.19x | 0.26x | 0.17x | 0.00x | -1.39x |
YoY = year-over-year change. Source: FMP..